B.O.S.S. Retirement Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Buy
1,417
+179
+14% +$41.7K 0.1% 116
2026
Q1
$303K Buy
1,238
+37
+3% +$8.62K 0.09% 131
2025
Q4
$249K Sell
1,201
-91
-7% -$18K 0.08% 154
2025
Q3
$240K Buy
+1,292
New +$221K 0.06% 174
2024
Q4
Sell
-30,797
Closed -$4.99M 250
2024
Q3
$4.99M Buy
30,797
+3,759
+14% +$599K 1.01% 30
2024
Q2
$3.95M Buy
27,038
+7,885
+41% +$1.17M 1.01% 31
2024
Q1
$3M Sell
19,153
-2,225
-10% -$354K 1.15% 23
2023
Q4
$3.35M Buy
21,378
+1,045
+5% +$160K 0.65% 36
2023
Q3
$3.17M Buy
20,333
+1,773
+10% +$293K 0.68% 33
2023
Q2
$3.07M Buy
18,560
+54
+0.3% +$8.71K 0.65% 34
2023
Q1
$2.87M Buy
18,506
+1,871
+11% +$302K 0.67% 39
2022
Q4
$2.94M Buy
+16,635
New +$2.87M 0.75% 30

Other funds holding JNJ

B.O.S.S. Retirement Advisors's JNJ Position: Q2 2026 in Review

B.O.S.S. Retirement Advisors increased its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, buying an estimated $41.7K and bringing the position to 1,417 shares worth $360K. The position accounts for 0.1% of the portfolio, ranked #116.

B.O.S.S. Retirement Advisors first reported a position in JNJ in Q4 2022 and has held it in 12 quarters since. The position peaked at $4.99M in Q3 2024. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • B.O.S.S. Retirement Advisors held 1,417 shares of Johnson & Johnson worth $360K as of Q2 2026.
  • B.O.S.S. Retirement Advisors bought 179 Johnson & Johnson shares in Q2 2026, an estimated $41.7K.
  • Johnson & Johnson made up 0.1% of B.O.S.S. Retirement Advisors's portfolio in Q2 2026, its #116 holding.
  • B.O.S.S. Retirement Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 12 quarters since.
  • B.O.S.S. Retirement Advisors's Johnson & Johnson position peaked at $4.99M in Q3 2024.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on B.O.S.S. Retirement Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.